Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

ARQTARQT
Showing 8 of 26 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in ARCUTIS BIOTHERAPEUTICS INC

NORTHERN TRUST CORP holds 1.1M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $27.8M as of 2026-Q2. The position was increased (+8.4% shares). ARQT represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$27.8M

Current Shares

1.1M

Total Value Change

+$19M

Total Shares Change

+122,060

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+8.4%
$27.8M0.0%$26.22
31
2026-Q1
Increased
976,512
+2.2%
$23M0.0%$23.56
29
2025-Q4
Increased
955,235
+1.6%
$27.7M0.0%$29.04
29
2025-Q3
Increased
940,202
+1.2%
$17.7M0.0%$18.85
29
2025-Q2
Decreased
928,688
-4.8%
$13M0.0%$14.02
0
2025-Q1
Decreased
976,070
-1.5%
$15.3M0.0%$15.64
0
2024-Q4
Increased
991,056
+5.8%
$13.8M0.0%$13.93
30
2024-Q3
Increased
936,515
+24.6%
$8.7M0.0%$9.30
34

Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used